CA - Bausch issues update on Xifaxan patent dispute with Norwich
2024-05-14 16:51:58 ET
More on Bausch Health Companies
- Why Bausch Health Stock Plunged After Posting First Quarter 2024 Results
- Bausch Health Companies (BHC) Q1 2024 Earnings Call Transcript
- Bausch Health Companies Inc. 2024 Q1 - Results - Earnings Call Presentation
- Bausch Health Companies GAAP EPS of -$0.17, revenue of $2.15B
- Bausch Health Companies Q1 2024 Earnings Preview